HEADLINES

Indian Market
Indian equity markets up by 0.58% . Nifty up by 32.35 pts and settle at 5610.00 Sensex up by 64.17 pts at 18528.44 Bank Nifty up by 338.75 pts at 10981.65

DAILY EQUITY NEWSLETTER

18 SEPTEMBER 2012
TH

Global Market
European markets were Down with FTSE down by 17.56 pts at 5897.99 ,CAC down by 18.18 pts at 3563.40 and DAX down by 16.48 pts at 7395.65 Dow future up by 11.00 pts at 13581.00

HEADLINES
Tata Motors global sales up 13% in August, JLR growth slows. RBI monetary policy: CRR cut by 25 bps, repo rate unchanged. Govt begins process to select m-banker for OIL divestment Tech Mahindra set to buy stake in Comviva: Sources

WWW.EPICRESEARCH.CO

09993959693

 MARKET ANALYSIS:
Key benchmark indices edged higher in choppy trade as the government after market hours on Friday, 14 September 2012, announced liberalization of foreign investment rules in retail, aviation and broadcasting sectors. While the government has allowed up to 51% FDI in multi-brand retail trading (MBRT), in the aviation sector the government has allowed foreign airlines to acquire up to 49% stake in Indian carriers. BSE Sensex, was provisionally up 64.17 points or 0.35%, off close to 185 points from the day's high and up about 50 points from the day's low. The S&P CNX Nifty was up 29.25 points or 0.52% to 5,606.90, as per provisional figures. The index hit a high of 5,652.20 in intraday trade, its highest level since 26 July 2011. From the 30-share Sensex pack, 18 stocks rose and rest of them fell. Reliance Infrastructure jumped 8.3%.Tata Motors jumped 3.37%Index heavyweight and cigarette maker ITC tumbled 5.52% to Rs 253.30 on profit booking. Among pharma stocks, Dr. Reddy's Lab, Glaxosmithkline Pharma, Ranbaxy Lab, Cadila Healthcare, Divi's Lab, Glenmark Pharma, Pfizer and Lupin lost 0.64% to 4.06%.

FIIs and DIIs

CATEGORY DATE BUY SELL NET

STOCKS TO WATCH GRAVITA AMBUJA STERLITE ADANI

FII DII

17-Sep-12 17-Sep-12

5889.33 2248.96

3637.16 3086.68

2252.17 -837.72

NIFTY DAILY PIVOTS

PIVOT NIFTY R4 5816 R3 5749 R2 5682 R1 5646 PP 5615 S1 5579 S2 5548 S3 5481 S4 5414

SCRIPS IN BAN PERIOD COREEDUTEC MCDOWELL-N PANTALOONR SUZLON WELCORP

WWW.EPICRESEARCH.CO

09993959693

-GAINERS AND LOOSERS

EXPERT OPINION
NIFTY

DAILY NIFTY GAINERS

SCRIPS RATE VOL. (000) PR. CLOSE NET CHAN GE % CHANGE

Nifty looks Bearish Strategy: Sell on Rise Support:5575

7.79 6.76 6.65 6.15 5.97

Reliance Infra DLF Bank Baroda IDFC JP Associ

507.75 231.25 726.05 147.50 78.10

3664.60 11776.92 2314.50 11232.17 25672.37

471.05 216.60 680.80 138.95 73.70

36.70 14.65 45.25 8.55 4.40

Resistance: 5645
BANK NIFTY

Bank Nifty looks Bearish Strategy: Sell on Rise Support:10915 Resistance:11045

PREVIOUS PERFORMANCE
TYPE SCRIP BHARTI AIRTEL DR REDDY AURO PHARMA JUBILANT FOODS B/S RESULT

DAILY NIFTY LOOSERS

SCRIPS RATE VOL. (000) PR. CLOSE NET % CHAN GE

CASH CASH FUTURE FUTURE

B S S S

TGT ACHIEVED TGT ACHIEVED TGT ACHIEVED NOT EXECUTED

ITC TCS

253.50 1342.10

18970.55 2544.45 909.25 2331.34 4235.00

268.25 1413.10 1747.50 350.20 548.05

-14.75 -71.00 -77.00 -11.45 -16.20

-5.50 -5.02 -4.41 -3.27 -2.96

Dr Reddys 1670.50 BPCL HUL 338.75 531.85

www.epicresearch.co

09993959693

MARKET CALLS
CASH
SCRIPS GRAVITA STERLITE ACTION SELL BUY LEVEL 166.00 103.25 1
ST

TARGET 164.70 104.05

ND

TARGET 163.20 105.00

RD

TARGET 161.00 106.50

STOP LOSS 167.30 102.45

FUTURE
SCRIPS . AMBUJA ADANI ACTION SELL BUY LEVEL 192.45 194.50 1
ST

TARGET 191.70 196.00

ND

TARGET 190.70 198.00

RD

TARGET 189.00 201.00

STOP LOSS 193.20 193.00

Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.